位置:首页 > 蛋白库 > CLD10_MOUSE
CLD10_MOUSE
ID   CLD10_MOUSE             Reviewed;         231 AA.
AC   Q9Z0S6; E9PVC8; E9PWP4; E9QMP1; Q8VC62; Q9CX57;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   22-JAN-2014, sequence version 2.
DT   03-AUG-2022, entry version 138.
DE   RecName: Full=Claudin-10;
GN   Name=Cldn10; Synonyms=Cldn10a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RA   Morita K., Furuse M., Tsukita S.;
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, SUBCELLULAR
RP   LOCATION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   ISOFORM 2.
RX   PubMed=16804102; DOI=10.1152/ajprenal.00138.2006;
RA   Van Itallie C.M., Rogan S., Yu A., Vidal L.S., Holmes J., Anderson J.M.;
RT   "Two splice variants of claudin-10 in the kidney create paracellular pores
RT   with different ion selectivities.";
RL   Am. J. Physiol. 291:F1288-F1299(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6), FUNCTION,
RP   SUBCELLULAR LOCATION, ALTERNATIVE SPLICING, TISSUE SPECIFICITY, AND DOMAIN.
RC   TISSUE=Kidney;
RX   PubMed=19383724; DOI=10.1242/jcs.040113;
RA   Gunzel D., Stuiver M., Kausalya P.J., Haisch L., Krug S.M., Rosenthal R.,
RA   Meij I.C., Hunziker W., Fromm M., Muller D.;
RT   "Claudin-10 exists in six alternatively spliced isoforms that exhibit
RT   distinct localization and function.";
RL   J. Cell Sci. 122:1507-1517(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=C57BL/6J; TISSUE=Wolffian duct;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   STRAIN=FVB/N; TISSUE=Kidney, and Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=14698084; DOI=10.1016/s0378-5955(03)00338-1;
RA   Kitajiri S.I., Furuse M., Morita K., Saishin-Kiuchi Y., Kido H., Ito J.,
RA   Tsukita S.;
RT   "Expression patterns of claudins, tight junction adhesion molecules, in the
RT   inner ear.";
RL   Hear. Res. 187:25-34(2004).
RN   [8]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=16520537; DOI=10.1292/jvms.68.149;
RA   Ohta H., Adachi H., Inaba M.;
RT   "Developmental changes in the expression of tight junction protein claudins
RT   in murine metanephroi and embryonic kidneys.";
RL   J. Vet. Med. Sci. 68:149-155(2006).
RN   [9]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=17075866; DOI=10.1002/dvdy.21001;
RA   Ohazama A., Sharpe P.T.;
RT   "Expression of claudins in murine tooth development.";
RL   Dev. Dyn. 236:290-294(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Pancreas;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   FUNCTION, TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=22891322; DOI=10.1073/pnas.1203834109;
RA   Breiderhoff T., Himmerkus N., Stuiver M., Mutig K., Will C., Meij I.C.,
RA   Bachmann S., Bleich M., Willnow T.E., Muller D.;
RT   "Deletion of claudin-10 (Cldn10) in the thick ascending limb impairs
RT   paracellular sodium permeability and leads to hypermagnesemia and
RT   nephrocalcinosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:14241-14246(2012).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=28771254; DOI=10.1038/gim.2017.71;
RA   Hadj-Rabia S., Brideau G., Al-Sarraj Y., Maroun R.C., Figueres M.L.,
RA   Leclerc-Mercier S., Olinger E., Baron S., Chaussain C., Nochy D.,
RA   Taha R.Z., Knebelmann B., Joshi V., Curmi P.A., Kambouris M.,
RA   Vargas-Poussou R., Bodemer C., Devuyst O., Houillier P., El-Shanti H.;
RT   "Multiplex epithelium dysfunction due to CLDN10 mutation: the HELIX
RT   syndrome.";
RL   Genet. Med. 20:190-201(2018).
CC   -!- FUNCTION: Plays a major role in tight junction-specific obliteration of
CC       the intercellular space, through calcium-independent cell-adhesion
CC       activity. Involved in the regulation of paracellular epithelia
CC       permeability to ions in multiple organs. It acts as a paracellular ion
CC       channel probably forming permselective pores; isoform 1 appears to
CC       create pores preferentially permeable to cations and isoform 2 for
CC       anions. In sweat glands and in the thick ascending limb (TAL) of
CC       Henle's loop in kidney, it controls paracellular sodium permeability
CC       which is essential for proper sweat production and renal function.
CC       {ECO:0000250|UniProtKB:P78369, ECO:0000269|PubMed:16804102,
CC       ECO:0000269|PubMed:19383724, ECO:0000269|PubMed:22891322}.
CC   -!- SUBUNIT: Can form homodimers both in trans (interaction between CLDN10
CC       molecules in opposing membranes) and in cis (interaction between CLDN10
CC       molecules within one membrane). {ECO:0000250|UniProtKB:P78369}.
CC   -!- INTERACTION:
CC       Q9Z0S6; Q8N6F1-2: CLDN19; Xeno; NbExp=2; IntAct=EBI-15799971, EBI-12256978;
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000269|PubMed:16804102, ECO:0000269|PubMed:19383724}. Cell
CC       membrane {ECO:0000269|PubMed:19383724}; Multi-pass membrane protein
CC       {ECO:0000255}. Endoplasmic reticulum {ECO:0000269|PubMed:19383724}.
CC       Note=Isoform 1, isoform 2 and isoform 4 localize in the cell membrane
CC       and at epithelial tight junctions, whereas isoform 3, isoform 5 and
CC       isoform 6 are detected in the endoplasmic reticulum.
CC       {ECO:0000269|PubMed:19383724}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=Cldn10b;
CC         IsoId=Q9Z0S6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cldn10a;
CC         IsoId=Q9Z0S6-2; Sequence=VSP_053551;
CC       Name=3; Synonyms=Cldn10a_i2;
CC         IsoId=Q9Z0S6-3; Sequence=VSP_053551, VSP_053553;
CC       Name=4; Synonyms=Cldn10a_i1;
CC         IsoId=Q9Z0S6-4; Sequence=VSP_053552;
CC       Name=5; Synonyms=Cldn10a_i3;
CC         IsoId=Q9Z0S6-5; Sequence=VSP_053552, VSP_053553;
CC       Name=6; Synonyms=Cldn10b_i1;
CC         IsoId=Q9Z0S6-6; Sequence=VSP_053553;
CC   -!- TISSUE SPECIFICITY: Strong expression detected in brain cortex and
CC       kidney and weak expression in lung and cecum. In kidney, detected in
CC       thick ascending limb (TAL) of Henle's loop and proximal convoluted
CC       tubule (PCT). Isoform 1 is widely expressed, with highest expression
CC       detected in brain cortex, kidney and lung. Isoform 2, isoform 3,
CC       isoform 4 and isoform 5 are only detected in kidney and uterus. In
CC       kidney, the expression of isoform 1 is highest in medulla, with
CC       transcripts being detected in medullary thick ascending limb of Henle's
CC       loop (mTAL) and outer and inner medullary collecting ducts, whereas
CC       isoform 2 (along with isoform 4) is more highly expressed in cortex,
CC       with transcripts being detected in PCT, mTAL and cortical collecting
CC       duct. Expressed in the inner ear where it is detected in organ of
CC       Corti, marginal cells of stria vascularis, Reissner's membrane and
CC       spiral limbus (at protein level) (PubMed:14698084). Expressed in
CC       salivary glands and skin (PubMed:28771254).
CC       {ECO:0000269|PubMed:14698084, ECO:0000269|PubMed:16804102,
CC       ECO:0000269|PubMed:19383724, ECO:0000269|PubMed:22891322,
CC       ECO:0000269|PubMed:28771254}.
CC   -!- DEVELOPMENTAL STAGE: Detected in developing kidney at 14 dpc, with
CC       levels increasing towards adulthood. Expressed during tooth
CC       development: at 12 dpc, detected in the thickening tooth epithelium, at
CC       13.5 dpc in the lingual basal epithelium of the bud epithelium, at 14.5
CC       dpc in lingual epithelium and between 18 dpc to postnatal day 1 in
CC       odontoblasts and stratum intermedium. {ECO:0000269|PubMed:16520537,
CC       ECO:0000269|PubMed:17075866}.
CC   -!- DOMAIN: The fourth transmembrane region (161-181), which is missing in
CC       isoform 3, isoform 5 and isoform 6, is necessary for integration into
CC       tight junctions. {ECO:0000269|PubMed:19383724}.
CC   -!- DISRUPTION PHENOTYPE: Conditional knockout in the thick ascending limb
CC       (TAL) of Henle's loop in kidney leads to hypocalcemia, hypermagnesemia,
CC       hyperphosphatemia and nephrocalcinosis. {ECO:0000269|PubMed:22891322}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative splicing of isoform
CC       2. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 5]: Produced by alternative splicing of isoform
CC       3. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF124425; AAD17320.1; -; mRNA.
DR   EMBL; AK020131; BAB32005.1; -; mRNA.
DR   EMBL; AC154377; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CT025524; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021770; AAH21770.1; -; mRNA.
DR   EMBL; BC029019; AAH29019.1; -; mRNA.
DR   CCDS; CCDS37009.1; -. [Q9Z0S6-2]
DR   CCDS; CCDS37010.1; -. [Q9Z0S6-1]
DR   CCDS; CCDS49566.1; -. [Q9Z0S6-3]
DR   RefSeq; NP_001153568.1; NM_001160096.1. [Q9Z0S6-4]
DR   RefSeq; NP_001153569.1; NM_001160097.1. [Q9Z0S6-3]
DR   RefSeq; NP_001153570.1; NM_001160098.1. [Q9Z0S6-5]
DR   RefSeq; NP_001153571.1; NM_001160099.1. [Q9Z0S6-6]
DR   RefSeq; NP_067361.2; NM_021386.4. [Q9Z0S6-1]
DR   RefSeq; NP_076367.2; NM_023878.3. [Q9Z0S6-2]
DR   AlphaFoldDB; Q9Z0S6; -.
DR   SMR; Q9Z0S6; -.
DR   DIP; DIP-48952N; -.
DR   DIP; DIP-48954N; -.
DR   IntAct; Q9Z0S6; 4.
DR   STRING; 10090.ENSMUSP00000097889; -.
DR   TCDB; 1.H.1.1.10; the claudin tight junction (claudin1) family.
DR   iPTMnet; Q9Z0S6; -.
DR   PhosphoSitePlus; Q9Z0S6; -.
DR   PaxDb; Q9Z0S6; -.
DR   PRIDE; Q9Z0S6; -.
DR   ProteomicsDB; 283283; -. [Q9Z0S6-1]
DR   ProteomicsDB; 283284; -. [Q9Z0S6-2]
DR   ProteomicsDB; 283285; -. [Q9Z0S6-3]
DR   ProteomicsDB; 283286; -. [Q9Z0S6-4]
DR   ProteomicsDB; 283287; -. [Q9Z0S6-5]
DR   ProteomicsDB; 283288; -. [Q9Z0S6-6]
DR   Antibodypedia; 4562; 274 antibodies from 32 providers.
DR   DNASU; 58187; -.
DR   Ensembl; ENSMUST00000047761; ENSMUSP00000041616; ENSMUSG00000022132. [Q9Z0S6-2]
DR   Ensembl; ENSMUST00000071546; ENSMUSP00000071476; ENSMUSG00000022132. [Q9Z0S6-3]
DR   Ensembl; ENSMUST00000100314; ENSMUSP00000097889; ENSMUSG00000022132. [Q9Z0S6-1]
DR   GeneID; 58187; -.
DR   KEGG; mmu:58187; -.
DR   UCSC; uc007uyw.2; mouse. [Q9Z0S6-2]
DR   UCSC; uc007uyx.2; mouse. [Q9Z0S6-1]
DR   UCSC; uc011zqb.1; mouse. [Q9Z0S6-4]
DR   UCSC; uc011zqc.1; mouse. [Q9Z0S6-5]
DR   UCSC; uc011zqd.1; mouse. [Q9Z0S6-3]
DR   UCSC; uc011zqe.1; mouse. [Q9Z0S6-6]
DR   CTD; 9071; -.
DR   MGI; MGI:1913101; Cldn10.
DR   VEuPathDB; HostDB:ENSMUSG00000022132; -.
DR   eggNOG; ENOG502QPNP; Eukaryota.
DR   GeneTree; ENSGT00940000155232; -.
DR   HOGENOM; CLU_076370_0_0_1; -.
DR   InParanoid; Q9Z0S6; -.
DR   OMA; CKEFISM; -.
DR   OrthoDB; 1164514at2759; -.
DR   PhylomeDB; Q9Z0S6; -.
DR   TreeFam; TF331936; -.
DR   BioGRID-ORCS; 58187; 3 hits in 74 CRISPR screens.
DR   ChiTaRS; Cldn10; mouse.
DR   PRO; PR:Q9Z0S6; -.
DR   Proteomes; UP000000589; Chromosome 14.
DR   RNAct; Q9Z0S6; protein.
DR   Bgee; ENSMUSG00000022132; Expressed in right kidney and 160 other tissues.
DR   Genevisible; Q9Z0S6; MM.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0070830; P:bicellular tight junction assembly; IBA:GO_Central.
DR   GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0006811; P:ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0043269; P:regulation of ion transport; ISS:UniProtKB.
DR   InterPro; IPR006187; Claudin.
DR   InterPro; IPR003554; Claudin10.
DR   InterPro; IPR017974; Claudin_CS.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   PANTHER; PTHR12002; PTHR12002; 1.
DR   PANTHER; PTHR12002:SF13; PTHR12002:SF13; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01383; CLAUDIN10.
DR   PROSITE; PS01346; CLAUDIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Endoplasmic reticulum;
KW   Ion transport; Membrane; Reference proteome; Tight junction; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..231
FT                   /note="Claudin-10"
FT                   /id="PRO_0000144758"
FT   TRANSMEM        1..21
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        22..80
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        81..101
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        102..115
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        116..136
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        137..160
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        161..181
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        182..231
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..73
FT                   /note="MASTALEIVAFVVSISGWVLVSSTLPTDYWKVSTIDGTVITTATYFANLWKI
FT                   CVTDSTGVANCKEFPSMLALD -> MSRAQISALVCGVGGFGALVAATTSNEWKVTTRA
FT                   SSVITATWVYQGLWMNCAGNALGSFHCRPHFTIFKVE (in isoform 2 and
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072, ECO:0000303|PubMed:16804102,
FT                   ECO:0000303|PubMed:19383724"
FT                   /id="VSP_053551"
FT   VAR_SEQ         1..73
FT                   /note="MASTALEIVAFVVSISGWVLVSSTLPTDYWKVSTIDGTVITTATYFANLWKI
FT                   CVTDSTGVANCKEFPSMLALD -> MSRAQISALVCGVGGFGALVAATTSNEWKVTTRA
FT                   SSVITATWVYQGLWMNCA (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:19383724"
FT                   /id="VSP_053552"
FT   VAR_SEQ         156..191
FT                   /note="Missing (in isoform 3, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:19383724"
FT                   /id="VSP_053553"
FT   CONFLICT        104
FT                   /note="T -> S (in Ref. 1; BAB32005)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="A -> V (in Ref. 1; AAD17320 and 6; AAH21770/
FT                   AAH29019)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219
FT                   /note="T -> A (in Ref. 1; AAD17320, 6; AAH21770/AAH29019
FT                   and 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   231 AA;  24695 MW;  80A28863B258DED2 CRC64;
     MASTALEIVA FVVSISGWVL VSSTLPTDYW KVSTIDGTVI TTATYFANLW KICVTDSTGV
     ANCKEFPSML ALDGYIQACR GLMIAAVSLG FFGSIFALFG MKCTKVGGSD QAKAKIACLA
     GIVFILSGLC SMTGCSLYAN KITTEFFDPL YMEQKYELGA ALFIGWAGAS LCIIGGVIFC
     FSISDNNKTP RMGYTYNGPT SAMSSRTKYQ GGEGDFKTTG PSKQFDKNAY V
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024